Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henrik Green

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Archives of Toxicology|May 18, 2025
In vitro CB<sub>1</sub> receptor activity of halogenated indazole synthetic cannabinoid receptor agonistsHenrik Green, Craig McKenzie, Elias Hamra, et al.
Gene|July 5, 2012
Identification of candidate SNPs for drug induced toxicity from differentially expressed genes in associated tissuesJohanna Hasmats, Ilya Kupershmidt, Cristina Rodríguez-Antona, et al.
British Journal of Pharmacology|July 14, 2026
Comprehensive in vitro profiling of traditional and emerging stimulants at monoamine transporters and the 5-HT<sub>2A</sub> receptorDarta Stalberga, Robert Kronstrand, Bianca Schranz, et al.
Nature Methods|June 27, 2018
A reassessment of DNA-immunoprecipitation-based genomic profilingAntonio Lentini, Cathrine Lagerwall, Svante Vikingsson, et al.
Pharmacogenomics|June 27, 2015
Role of cytochrome P450 2C8*3 (CYP2C8*3) in paclitaxel metabolism and paclitaxel-induced neurotoxicityMi-Young Lee, María Apellániz-Ruiz, Inger Johansson, et al.
ESC Heart Failure|April 18, 2020
Monozygotic twins with myocarditis and a novel likely pathogenic desmoplakin gene variantAntheia Kissopoulou, Eva Fernlund, Christina Holmgren, et al.
Oncology Letters|December 20, 2024
Intratumoural expression of dihydropyrimidine dehydrogenase is an independent prognostic factor in resected pancreatic ductal adenocarcinoma treated with adjuvant gemcitabineHakon Blomstrand, Malin Bodarve, Fredrik Groth, et al.
Drug Testing and Analysis|December 8, 2023
Log D<sub>7.4</sub> and plasma protein binding of synthetic cannabinoid receptor agonists and a comparison of experimental and predicted lipophilicityAndrew M Brandon, Steven R Baginski, Caroline Peet, et al.
Archives of Toxicology|May 20, 2026
Global emergence and γ-aminobutyric acid type A (GABA<sub>A</sub>) receptor activity of the new designer benzodiazepine ethylbromazolamCaitlyn Norman, Dean Acreman, Meera Bissram, et al.
Genes & Development|April 4, 2015
Increased Rrm2 gene dosage reduces fragile site breakage and prolongs survival of ATR mutant miceAndres J Lopez-Contreras, Julia Specks, Jacqueline H Barlow, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Archives of Toxicology|May 18, 2025
In vitro CB<sub>1</sub> receptor activity of halogenated indazole synthetic cannabinoid receptor agonistsHenrik Green, Craig McKenzie, Elias Hamra, et al.
Gene|July 5, 2012
Identification of candidate SNPs for drug induced toxicity from differentially expressed genes in associated tissuesJohanna Hasmats, Ilya Kupershmidt, Cristina Rodríguez-Antona, et al.
British Journal of Pharmacology|July 14, 2026
Comprehensive in vitro profiling of traditional and emerging stimulants at monoamine transporters and the 5-HT<sub>2A</sub> receptorDarta Stalberga, Robert Kronstrand, Bianca Schranz, et al.
Nature Methods|June 27, 2018
A reassessment of DNA-immunoprecipitation-based genomic profilingAntonio Lentini, Cathrine Lagerwall, Svante Vikingsson, et al.
Pharmacogenomics|June 27, 2015
Role of cytochrome P450 2C8*3 (CYP2C8*3) in paclitaxel metabolism and paclitaxel-induced neurotoxicityMi-Young Lee, María Apellániz-Ruiz, Inger Johansson, et al.
ESC Heart Failure|April 18, 2020
Monozygotic twins with myocarditis and a novel likely pathogenic desmoplakin gene variantAntheia Kissopoulou, Eva Fernlund, Christina Holmgren, et al.
Oncology Letters|December 20, 2024
Intratumoural expression of dihydropyrimidine dehydrogenase is an independent prognostic factor in resected pancreatic ductal adenocarcinoma treated with adjuvant gemcitabineHakon Blomstrand, Malin Bodarve, Fredrik Groth, et al.
Drug Testing and Analysis|December 8, 2023
Log D<sub>7.4</sub> and plasma protein binding of synthetic cannabinoid receptor agonists and a comparison of experimental and predicted lipophilicityAndrew M Brandon, Steven R Baginski, Caroline Peet, et al.
Archives of Toxicology|May 20, 2026
Global emergence and γ-aminobutyric acid type A (GABA<sub>A</sub>) receptor activity of the new designer benzodiazepine ethylbromazolamCaitlyn Norman, Dean Acreman, Meera Bissram, et al.
Genes & Development|April 4, 2015
Increased Rrm2 gene dosage reduces fragile site breakage and prolongs survival of ATR mutant miceAndres J Lopez-Contreras, Julia Specks, Jacqueline H Barlow, et al.
Pageof 7